Pharmaceuticals, Biotechnology and Life Sciences
Pacific Biosciences of California is working with commercial, academic and government research teams that are investigating SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
IBM Releases Novel AIBM Research has been actively developing new cloud and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery.
PatientSource has announced that it will be offering an adapted version of its Electronic Patient Record (EPR) software to healthcare organisations across the globe, completely free of charge with minimal cloud hosting costs, to help combat the Coronavirus pandemic.
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE: IQV), a leader in Human Data Science, today announced its new…
CHICAGO–(BUSINESS WIRE)–iBIO today announced that since the March 23rd launch of the iBIO COVID-19 PPE Response Fund, the Illinois life…
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against…
First in-vitro validation of impact of Ivermectin on Covid-19 by Australian researchers MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: MedinCell (Paris:MEDCL) Researchers at…
DUBLIN–(BUSINESS WIRE)–ResearchAndMarkets.com identifies Over-the-counter Drugs as one of the key industries seeing increased demand due to the Coronavirus pandemic. With…
Care Access Research on Friday said it was leading a validation trial with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.
Novartis said on Thursday it aims to start a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for the treatment of a type of severe immune overreaction called cytokine storm that can lead to life-threatening respiratory complications in patients with COVID-19.